Results 201 to 210 of about 2,027,812 (357)

[The movement for reassessing education and research in nursing history]. [PDF]

open access: gold, 2004
Ieda de Alencar Barreira   +1 more
openalex   +1 more source

Implementation of mass pharmacogenetic testing: Dihydropyrimidine dehydrogenase testing prior to fluoropyrimidine treatment for patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Pharmacogenomics enables personalization of drug therapy improving effectiveness and/or safety. Dihydropyrimidine dehydrogenase [DPYD] testing prior to fluoropyrimidine chemotherapy was commissioned by NHS England in response to an update from the Medicines and Healthcare products Regulatory Agency.
Nisha Shaunak   +5 more
wiley   +1 more source

Implementing physician‐led medication reviews for patients with diabetes and severe mental disorder: A randomized controlled trial

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Patients with severe mental disorder and diabetes may be exposed to inappropriate polypharmacy increasing the risk of side effects and drug interactions. Although medication reviews may facilitate short‐term deprescribing, they are not known to affect clinical outcomes.
Johan Frederik Mebus Meyer Christensen   +2 more
wiley   +1 more source

Insights into the relationship between anxiety and attitudes toward artificial intelligence among nursing students. [PDF]

open access: yesBMC Nurs
Ayed A   +8 more
europepmc   +1 more source

Turkish translation and cultural adaptation of the Ascertaining Barriers to Compliance taxonomy for medication adherence

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this study was to create a Turkish version of the Ascertaining Barriers to Compliance (ABC) taxonomy for medication adherence. Methods A systematic literature search was conducted, followed by a national Delphi study using suggested methods of the International Society for Medication Adherence for translation of the ABC taxonomy for ...
Cansu Goncuoglu   +5 more
wiley   +1 more source

A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt   +7 more
wiley   +1 more source

Transforming nursing education: the power of educational leadership in optimizing time management and competency. [PDF]

open access: yesBMC Nurs
Amin SM   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy